Dystonia Parkinson's Disease
Conditions
Interventions
Next to the standard botulinum toxin treatment of varus tilt of the hindfoot,
participants in the intervention group will receive additional daily functional
gait training via home-exercises for 8 w
Sponsors
Radboud Universitair Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: The main inclusion criterium consists of idiopathic Parkinson*s disease and the presence of dystonia resulting in varus tilt of the hindfoot when walking. In addition, participants should be able to walk 100 meters and be able to follow instructions.
Exclusion criteria
Exclusion criteria: Participants will be excluded if they: • Have severe cognitive impairments • Have other neurologic or orthopedic impairments that cause problems when walking • Are not able to walk 100 meters independently
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure of the study is the evaluation of predefined personal goals using the COPM. This outcome measure is measured at baseline, and at 8 and 16 weeks after treatment with botulinum toxin. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures include comfortable and maximum gait speed, balance performance (Mini-BEST), gait variability, severity of dystonia (using the MDS-dystonia rating scale) and time to re-injection. | — |
Countries
Netherlands
Outcome results
None listed